$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 8-K Financial Statement

#000088559022000027 Filed on May 11, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$2.196B	$8.434B	$2.213B
YoY Change	-0.77%	5.07%	-0.49%
Cost Of Revenue	$626.0M	$2.394B	$645.0M
YoY Change	-2.95%	6.45%	1.57%
Gross Profit	$1.570B	$6.040B	$1.568B
YoY Change	0.13%	4.53%	-1.32%
Gross Profit Margin	71.49%	71.61%	70.85%
Selling, General & Admin	$680.0M	$2.624B	$636.0M
YoY Change	6.92%	10.86%	-4.79%
% of Gross Profit	43.31%	43.44%	40.56%
Research & Development	$117.0M	$465.0M	$119.0M
YoY Change	-1.68%	2.88%	4.39%
% of Gross Profit	7.45%	7.7%	7.59%
Depreciation & Amortization	$363.0M	$177.0M	$428.0M
YoY Change	-15.19%	-1.67%	-13.01%
% of Gross Profit	23.12%	2.93%	27.3%
Operating Expenses	$1.117B	$3.089B	$1.138B
YoY Change	-1.85%	9.58%	-6.49%
Operating Profit	$453.0M	$450.0M	-$5.000M
YoY Change	-9160.0%	-33.43%	-99.54%
Interest Expense	-$346.0M	-$1.412B	-$381.0M
YoY Change	-9.19%	-8.96%	-2.81%
% of Operating Profit	-76.38%	-313.78%
Other Income/Expense, Net		-$373.0M
YoY Change		-25.7%
Pretax Income	$21.00M	-$1.024B	-$394.0M
YoY Change	-105.33%	9.64%	-73.2%
Income Tax	-$51.00M	-$87.00M	-$242.0M
% Of Pretax Income	-242.86%
Net Earnings	$69.00M	-$948.0M	-$153.0M
YoY Change	-145.1%	69.29%	-89.91%
Net Earnings / Revenue	3.14%	-11.24%	-6.91%
Basic Earnings Per Share		-$2.64
Diluted Earnings Per Share	$191.6K	-$2.64	-$429.9K
COMMON SHARES
Basic Shares Outstanding	359.3M shares	358.9M shares	355.2M shares
Diluted Shares Outstanding		358.9M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$582.0M	$582.0M	$605.0M
YoY Change	-3.8%	-3.8%	-81.34%
Cash & Equivalents	$582.0M	$582.0M	$605.0M
Short-Term Investments
Other Short-Term Assets	$2.257B	$2.257B	$2.066B
YoY Change	9.24%	9.24%	164.87%
Inventory	$993.0M	$993.0M	$1.094B
Prepaid Expenses
Receivables	$1.775B	$1.775B	$1.577B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.607B	$5.607B	$5.342B
YoY Change	4.96%	4.96%	-23.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.598B	$1.845B	$1.567B
YoY Change	1.98%	1.04%	6.89%
Goodwill	$12.46B		$13.04B
YoY Change	-4.5%		-0.62%
Intangibles	$6.948B		$8.445B
YoY Change	-17.73%		-17.21%
Long-Term Investments
YoY Change
Other Assets	$340.0M	$2.345B	$664.0M
YoY Change	-48.8%	-7.75%	61.56%
Total Long-Term Assets	$23.60B	$23.60B	$25.86B
YoY Change	-8.75%	-8.75%	-3.86%
TOTAL ASSETS
Total Short-Term Assets	$5.607B	$5.607B	$5.342B
Total Long-Term Assets	$23.60B	$23.60B	$25.86B
Total Assets	$29.20B	$29.20B	$31.20B
YoY Change	-6.4%	-6.4%	-7.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$407.0M	$407.0M	$337.0M
YoY Change	20.77%	20.77%	-33.0%
Accrued Expenses	$4.791B	$4.693B	$4.576B
YoY Change	4.7%	6.22%	1.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00		$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$5.198B	$5.198B	$4.913B
YoY Change	5.8%	5.8%	-21.37%
LONG-TERM LIABILITIES
Long-Term Debt	$22.65B	$22.65B	$23.93B
YoY Change	-5.31%	-5.31%	-2.98%
Other Long-Term Liabilities	$653.0M	$855.0M	$1.012B
YoY Change	-35.47%	-30.37%	18.92%
Total Long-Term Liabilities	$23.31B	$23.51B	$24.94B
YoY Change	-6.54%	-6.54%	-2.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.198B	$5.198B	$4.913B
Total Long-Term Liabilities	$23.31B	$23.51B	$24.94B
Total Liabilities	$29.24B	$29.31B	$30.59B
YoY Change	-4.44%	-4.42%	-6.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.961B		-$8.013B
YoY Change	11.83%		7.53%
Common Stock	$10.78B		$10.68B
YoY Change	0.92%		0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$106.0M	-$106.0M	$535.0M
YoY Change
Total Liabilities & Shareholders Equity	$29.20B	$29.20B	$31.20B
YoY Change	-6.4%	-6.4%	-7.87%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$69.00M	-$948.0M	-$153.0M
YoY Change	-145.1%	69.29%	-89.91%
Depreciation, Depletion And Amortization	$363.0M	$177.0M	$428.0M
YoY Change	-15.19%	-1.67%	-13.01%
Cash From Operating Activities	$24.00M	$1.426B	$394.0M
YoY Change	-93.91%	28.35%	68.38%
INVESTING ACTIVITIES
Capital Expenditures	-$83.00M	$269.0M	-$84.00M
YoY Change	-1.19%	-10.93%	-1.18%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$3.000M	$692.0M	$0.00
YoY Change		1341.67%
Cash From Investing Activities	-$80.00M	$409.0M	-$84.00M
YoY Change	-4.76%	-256.7%	-1.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$3.440B
YoY Change		-39.03%
Cash From Financing Activities	275.0M	-$1.513B	-503.0M
YoY Change	-154.67%	-34.05%	-122.31%
NET CHANGE
Cash From Operating Activities	24.00M	$1.426B	$394.0M
Cash From Investing Activities	-80.00M	$409.0M	-84.00M
Cash From Financing Activities	275.0M	-$1.513B	-503.0M
Net Change In Cash	219.0M	$303.0M	$394.0M
YoY Change	-44.42%	-121.22%	68.38%
FREE CASH FLOW
Cash From Operating Activities	$24.00M	$1.426B	$394.0M
Capital Expenditures	-$83.00M	$269.0M	-$84.00M
Free Cash Flow	$107.0M	$1.157B	$478.0M
YoY Change	-77.62%	43.02%	49.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q2	dei	Document Type DocumentType	8-K
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-05-10
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	Bausch Health Companies Inc.
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2022Q2	dei	Entity Address Country EntityAddressCountry	CA
CY2022Q2	dei	Entity File Number EntityFileNumber	001-14956
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0448205
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 St. Elzéar Blvd. West
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Laval
CY2022Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	QC
CY2022Q2	dei	Entity Address Country EntityAddressCountry	CA
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	H7L 4A8
CY2022Q2	dei	City Area Code CityAreaCode	514
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	744-6792
CY2022Q2	dei	Written Communications WrittenCommunications	false
CY2022Q2	dei	Soliciting Material SolicitingMaterial	false
CY2022Q2	dei	Pre Commencement Tender Offer PreCommencementTenderOffer	false
CY2022Q2	dei	Pre Commencement Issuer Tender Offer PreCommencementIssuerTenderOffer	false
CY2022Q2	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
CY2022Q2	dei	Trading Symbol TradingSymbol	BHC
CY2022Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605000000	USD
CY2021Q4	bhc	Restricted Cash And Other Settlement Deposits Current RestrictedCashAndOtherSettlementDepositsCurrent	1537000000	USD
CY2020Q4	bhc	Restricted Cash And Other Settlement Deposits Current RestrictedCashAndOtherSettlementDepositsCurrent	1211000000	USD
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1775000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1577000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	993000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1094000000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	720000000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	855000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	5607000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	5342000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1598000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1567000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6948000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8445000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	12457000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	13044000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2252000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2137000000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	340000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	664000000	USD
CY2021Q4	us-gaap	Assets Assets	29202000000	USD
CY2020Q4	us-gaap	Assets Assets	31199000000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	407000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	337000000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4791000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4576000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5198000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4913000000	USD
CY2021Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	202000000	USD
CY2020Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	216000000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22654000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23925000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	529000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	528000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	653000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1012000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	29236000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	30594000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	359405748	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	359405748	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	355422347	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	355422347	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10317000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10227000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	462000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	454000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8961000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8013000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1924000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2133000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-106000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	535000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	72000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	70000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29202000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31199000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8434000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8027000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8601000000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2624000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2367000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2554000000	USD
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	465000000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	452000000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	471000000	USD
CY2021	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1375000000	USD
CY2020	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1645000000	USD
CY2019	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1897000000	USD
CY2021	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
CY2020	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2019	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	234000000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	114000000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75000000	USD
CY2021	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	50000000	USD
CY2020	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	22000000	USD
CY2019	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	31000000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-373000000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-502000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1426000000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	7984000000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	7351000000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	8804000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	450000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	676000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-203000000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	1426000000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	1534000000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	1612000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-59000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42000000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7000000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-30000000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1024000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-934000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1837000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-87000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-375000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-937000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-559000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-1783000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-948000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-1788000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.64
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.58
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.08
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.08
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	358900000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	358900000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	355000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	355000000.0	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	352100000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	352100000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-937000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-559000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-1783000000	USD
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	24000000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-15000000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-8000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	USD
CY2021	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-10000000	USD
CY2020	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-1000000	USD
CY2019	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-2000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	1000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	2000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-2000000	USD
CY2021	bhc	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	-3000000	USD
CY2020	bhc	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	0	USD
CY2019	bhc	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	-2000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-28000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	16000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	14000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-158000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-29000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	64000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-130000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1067000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-604000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1733000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	12000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1079000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-607000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1737000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2815000000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5000000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	102000000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	40000000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	13000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-1783000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1136000000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5000000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	105000000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	30000000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6000000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-559000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605000000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22000000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	128000000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	52000000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	340000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-937000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-130000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-937000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-559000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-1783000000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1552000000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1825000000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2075000000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	55000000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	61000000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	63000000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	234000000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	114000000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75000000	USD
CY2021	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
CY2020	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2019	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2021	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	11000000	USD
CY2020	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	48000000	USD
CY2019	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	12000000	USD
CY2021	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	60000000	USD
CY2020	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	60000000	USD
CY2019	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	75000000	USD
CY2021	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-225000000	USD
CY2020	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-475000000	USD
CY2019	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-230000000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2000000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	31000000	USD
CY2021	bhc	Gain Loss Related To Litigation Settlement Gross GainLossRelatedToLitigationSettlementGross	-569000000	USD
CY2020	bhc	Gain Loss Related To Litigation Settlement Gross GainLossRelatedToLitigationSettlementGross	-442000000	USD
CY2019	bhc	Gain Loss Related To Litigation Settlement Gross GainLossRelatedToLitigationSettlementGross	-1401000000	USD
CY2021	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	351000000	USD
CY2020	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	168000000	USD
CY2019	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	15000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	128000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	105000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	102000000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-6000000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-8000000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-7000000	USD
CY2021	bhc	Derivative Gain Excluded Component DerivativeGainExcludedComponent	20000000	USD
CY2020	bhc	Derivative Gain Excluded Component DerivativeGainExcludedComponent	23000000	USD
CY2019	bhc	Derivative Gain Excluded Component DerivativeGainExcludedComponent	9000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-59000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42000000	USD
CY2021	bhc	Payment For Contingent Consideration Liability Including Accretion Operating Activities PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities	16000000	USD
CY2020	bhc	Payment For Contingent Consideration Liability Including Accretion Operating Activities PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities	1000000	USD
CY2019	bhc	Payment For Contingent Consideration Liability Including Accretion Operating Activities PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities	1000000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	41000000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	18000000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-36000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	229000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-170000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39000000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	209000000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4000000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-12000000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	121000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-471000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-149000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1426000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1111000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1501000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	180000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1428000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2521000000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14000000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7000000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	269000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	302000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	270000000	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	19000000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4000000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	16000000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15000000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	8000000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10000000	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	669000000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	21000000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	45000000	USD
CY2021	bhc	Interest Settlement On Cross Currency Swaps InterestSettlementOnCrossCurrencySwaps	27000000	USD
CY2020	bhc	Interest Settlement On Cross Currency Swaps InterestSettlementOnCrossCurrencySwaps	23000000	USD
CY2019	bhc	Interest Settlement On Cross Currency Swaps InterestSettlementOnCrossCurrencySwaps	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	409000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-261000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-419000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2100000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3455000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5960000000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3440000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5642000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4406000000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	USD
CY2019	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	12000000	USD
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1000000	USD
CY2019	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	12000000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	52000000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	30000000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	40000000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	83000000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	35000000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	35000000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	48000000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	39000000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	28000000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1513000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2294000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1443000000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-19000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	303000000	USD
CY2020Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	1816000000	USD
CY2019Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	3244000000	USD
CY2018Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	723000000	USD
CY2021Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	2119000000	USD
CY2020Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	1816000000	USD
CY2019Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	3244000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3243000000	USD
CY2021Q4	bhc	Restricted Cash And Other Settlement Deposits Current RestrictedCashAndOtherSettlementDepositsCurrent	1537000000	USD
CY2020Q4	bhc	Restricted Cash And Other Settlement Deposits Current RestrictedCashAndOtherSettlementDepositsCurrent	1211000000	USD
CY2019Q4	bhc	Restricted Cash And Other Settlement Deposits Current RestrictedCashAndOtherSettlementDepositsCurrent	1000000	USD
CY2021Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	2119000000	USD
CY2020Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	1816000000	USD
CY2019Q4	bhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndOtherSettlementDeposits	3244000000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESSBausch Health Companies Inc. (the “Company”), formerly known as Valeant Pharmaceuticals International, Inc., is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act.
CY2021Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
CY2021Q4	bhc	Business Separation And Proposed Initial Public Offering Number Of Companies To Be Established BusinessSeparationAndProposedInitialPublicOfferingNumberOfCompaniesToBeEstablished	3	company
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the Company's Consolidated Financial Statements, management is required to make estimates and assumptions. This includes estimates and assumptions regarding the nature, timing and extent of the impacts that the COVID-19 pandemic will have on its operations and cash flows. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates, chargebacks, discounts and allowances and distribution fees paid to certain wholesalers; useful lives of amortizable intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment, assessing compliance with debt covenants and making going concern assessments; reporting unit fair values for testing goodwill for impairment and allocating goodwill to new reporting unit structure on a relative fair value basis; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; fair value of cross-currency swaps; fair value of foreign currency exchange contracts; and the recognition of the fair value of assets and liabilities acquired in a business combination, including the fair value of contingent consideration. Under certain product manufacturing and supply agreements, management uses information from the Company’s commercialization counterparties to arrive at estimates for future returns, rebates and chargebacks. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s Consolidated Financial Statements could be materially impacted.</span></div>
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in the first quarter of 2022, the Company operates in the following reportable segments: (i) Bausch + Lomb, (ii) Salix, (iii) International, (iv) Solta Medical and (v) Diversified Products. Prior to the first quarter of 2022, the Company operated in the following reportable segments: (i) Bausch + Lomb, (ii) Salix, (iii) International, (iv) Ortho Dermatologics and (v) Diversified Products. All segment revenues and profits for the periods presented have been recast to conform to the 2022 segment reporting structure. See Note 22, “SEGMENT INFORMATION” for additional information.</span></div>
CY2021	bhc	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, trade receivables, cross-currency swaps and foreign currency exchange contracts.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than three months.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash deposited at banks may exceed the amount of insurance provided on such deposits. Generally, these cash deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate such risks by spreading its risk across multiple counterparties and monitoring the risk profiles of these counterparties.</span></div>The Company’s trade receivables primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic regions. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Argentina, Brazil, Egypt, Greece, among other members of the European Union, Turkey, Ukraine and Venezuela have been weak in recent years.
CY2021	bhc	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2021	bhc	Concentration Risk Percentageof Net Trade Receivables ConcentrationRiskPercentageofNetTradeReceivables	0.44
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	Allowance for Credit LossesAn allowance is maintained for potential credit losses. The Company estimates the current expected credit loss on its receivables based on various factors, including historical credit loss experience, customer credit worthiness, value of collaterals (if any), and any relevant current and reasonably supportable future economic factors. Additionally, the Company generally estimates the expected credit loss on a pool basis when customers are deemed to have similar risk characteristics. Trade receivable balances are written off against the allowance when it is deemed probable that the trade receivable will not be collected. Trade receivables, net are stated net of certain sales provisions and the allowance for credit losses.
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	48000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	48000000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	47000000	USD
CY2021	bhc	Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate	0	USD
CY2020	bhc	Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate	1000000	USD
CY2019	bhc	Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate	0	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2000000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10000000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3000000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	12000000	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10000000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	2000000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3000000	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1000000	USD
CY2021	bhc	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	1000000	USD
CY2020	bhc	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	3000000	USD
CY2019	bhc	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	48000000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2050000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	5036000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	5273000000	USD
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1813000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	5428000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	5378000000	USD
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1863000000	USD
CY2021	bhc	Cash Discounts And Allowances Settlement Period CashDiscountsAndAllowancesSettlementPeriod	P1M
CY2021	bhc	Sensitivity Analysis Impact Of1 Percent Change In Estimated Return Rate Income Loss Before Tax SensitivityAnalysisImpactOf1PercentChangeInEstimatedReturnRateIncomeLossBeforeTax	81000000	USD
CY2021	bhc	Sensitivity Analysis Impact Of1 Percent Change In Volume Of Product Sold Through To Medicaid Plan Participants Income Loss Before Tax SensitivityAnalysisImpactOf1PercentChangeInVolumeOfProductSoldThroughToMedicaidPlanParticipantsIncomeLossBeforeTax	76000000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	515000000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	451000000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	544000000	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	60000000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	45000000	USD
CY2021	bhc	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.50
CY2021	bhc	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2021	bhc	Highly Liquid Investments Maturity Period HighlyLiquidInvestmentsMaturityPeriod	P3M
CY2021	bhc	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.10
CY2020	bhc	Number Of Other Businesses Acquired NumberOfOtherBusinessesAcquired	0	businessCombination
CY2021	bhc	Number Of Other Businesses Acquired NumberOfOtherBusinessesAcquired	0	businessCombination
CY2019	bhc	Number Of Other Businesses Acquired NumberOfOtherBusinessesAcquired	0	businessCombination
CY2021Q2	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	10000000	USD
CY2021Q4	bhc	Additional Payments To Acquire Equity Securities Fvni Expected AdditionalPaymentsToAcquireEquitySecuritiesFVNIExpected	0	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	328000000	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	316000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	11000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	48000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	99000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	36000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	1000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	0	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	241000000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	328000000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	39000000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	112000000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	202000000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	216000000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	279000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	286000000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	112000000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	143000000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	602000000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	665000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	993000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1094000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3418000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3348000000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1820000000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1781000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1598000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1567000000	USD
CY2021	us-gaap	Depreciation Depreciation	177000000	USD
CY2020	us-gaap	Depreciation Depreciation	180000000	USD
CY2019	us-gaap	Depreciation Depreciation	178000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25430000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20180000000	USD
CY2019Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5250000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25481000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18741000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6740000000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27128000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20180000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6948000000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27186000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18741000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8445000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1181000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1026000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	902000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	795000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	664000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	682000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5250000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	13142000000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3000000	USD
CY2019	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	18000000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	13126000000	USD
CY2020	bhc	Goodwill Transfers Related To Sale Of Business Unit GoodwillTransfersRelatedToSaleOfBusinessUnit	18000000	USD
CY2020	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	217000000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	117000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	13044000000	USD
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	469000000	USD
CY2021Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0588
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-118000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	12457000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8434000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8027000000	USD
CY2021	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTax	407000000	USD
CY2020Q2	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.23
CY2020Q3	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.03
CY2020Q4	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.01
CY2021Q1	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.40
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.45
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4180000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	767000000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4791000000	USD
CY2021Q4	bhc	Legalsettlementsandrelatedfees Legalsettlementsandrelatedfees	1890000000	USD
CY2020Q4	bhc	Legalsettlementsandrelatedfees Legalsettlementsandrelatedfees	1672000000	USD
CY2021Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	908000000	USD
CY2020Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	747000000	USD
CY2021Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	482000000	USD
CY2020Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	575000000	USD
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	336000000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	316000000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	328000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	341000000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	98000000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	158000000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	749000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4576000000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	22870000000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	22654000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	24185000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	23925000000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22654000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23925000000	USD
CY2021	bhc	Debt Instrument Redemption Price Percentage Changein Control DebtInstrumentRedemptionPricePercentageChangeinControl	1.01
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8000000	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38000000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-27000000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	41000000	USD
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0602
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	285000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	9723000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1500000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	11362000000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	22870000000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	216000000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	22654000000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	44000000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2021	bhc	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	43000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	247000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	259000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	52000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	214000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	227000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	264000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	279000000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	67000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	65000000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	62000000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	12000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	12000000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	16000000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	76000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	74000000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	73000000	USD
CY2021	bhc	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	46000000	USD
CY2020	bhc	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	39000000	USD
CY2019	bhc	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	47000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	64000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	53000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	41000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	38000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	100000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	330000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	66000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	264000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	214000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	128000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	105000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	102000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	128000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	105000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	102000000	USD
CY2019	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	37000000	USD
CY2021	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	440000000	USD
CY2020	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	420000000	USD
CY2019	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	434000000	USD
CY2021	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	25000000	USD
CY2020	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	32000000	USD
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	465000000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	452000000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	471000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-356000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-422000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1401000000	USD
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	8000000	USD
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	32000000	USD
CY2019	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	41000000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	31000000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11000000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	48000000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	20000000	USD
CY2021	bhc	Other Income Expense Net OtherIncomeExpenseNet	0	USD
CY2020	bhc	Other Income Expense Net OtherIncomeExpenseNet	1000000	USD
CY2019	bhc	Other Income Expense Net OtherIncomeExpenseNet	-5000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-373000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-502000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1426000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-356000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-422000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1401000000	USD
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	32000000	USD
CY2019	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	41000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-323000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-410000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2396000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-701000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-524000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	559000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1024000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-934000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1837000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	128000000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	8000000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	12000000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-74000000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	216000000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	116000000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-51000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	224000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5000000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-16000000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-590000000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-187000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-36000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-599000000	USD
CY2021	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	59000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-182000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-87000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-375000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1024000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-934000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1837000000	USD
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-275000000	USD
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-251000000	USD
CY2019	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-494000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	9000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	9000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	7000000	USD
CY2020	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	-26000000	USD
CY2019	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	99000000	USD
CY2021	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	-28000000	USD
CY2020	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	-62000000	USD
CY2019	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	-21000000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-40000000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-687000000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	142000000	USD
CY2021	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-112000000	USD
CY2020	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	163000000	USD
CY2019	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	350000000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	198000000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	128000000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-186000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	99000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2021	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	0	USD
CY2020	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	338000000	USD
CY2019	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	13000000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-87000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-375000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-54000000	USD
CY2021Q4	bhc	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	2973000000	USD
CY2020Q4	bhc	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	2924000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	991000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1004000000	USD
CY2021Q4	bhc	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	173000000	USD
CY2020Q4	bhc	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	172000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2065000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1999000000	USD
CY2020	bhc	Unrecognized Tax Benefits Net Increase Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingFromCurrentPeriodTaxPositions	66000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	16000000	USD
CY2021Q4	bhc	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	52000000	USD
CY2020Q4	bhc	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	55000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	14000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	20000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	9000000	USD
CY2021Q4	bhc	Deferred Tax Assets Prepaid Expenses DeferredTaxAssetsPrepaidExpenses	26000000	USD
CY2020Q4	bhc	Deferred Tax Assets Prepaid Expenses DeferredTaxAssetsPrepaidExpenses	27000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	17000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	38000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4287000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4251000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2222000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2252000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	188000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	228000000	USD
CY2021Q4	bhc	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	44000000	USD
CY2020Q4	bhc	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	89000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	110000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	71000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Currency Transaction Gains DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Currency Transaction Gains DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains	2000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	342000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	390000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1723000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1609000000	USD
CY2021Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	927000000	USD
CY2020Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	1025000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	271000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	414000000	USD
CY2021	bhc	Unrecognized Tax Benefits Net Increase Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingFromCurrentPeriodTaxPositions	79000000	USD
CY2021	bhc	Unrecognized Tax Benefits Net Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsNetDecreaseResultingFromPriorPeriodTaxPositions	177000000	USD
CY2020	bhc	Unrecognized Tax Benefits Net Increase Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingFromPriorPeriodTaxPositions	42000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	41000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	49000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-8000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	4000000	USD
CY2021	bhc	Income Tax Number Of Subsidiaries File Federal Income Tax Returns IncomeTaxNumberOfSubsidiariesFileFederalIncomeTaxReturns	1	subsidiary
CY2021	us-gaap	Income Tax Examination Estimate Of Possible Loss IncomeTaxExaminationEstimateOfPossibleLoss	2100000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1025000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1002000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	654000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	79000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	66000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	361000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	121000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	171000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	63000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	129000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	209000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	58000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	169000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	5000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	18000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	927000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1025000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1002000000	USD
CY2021Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	104000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-948000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-1788000000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	358900000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	358900000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	355000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	355000000.0	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	352100000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	352100000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.64
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.58
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.08
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.08
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1419000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1474000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1537000000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	240000000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	162000000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	172000000	USD
CY2021Q4	bhc	Legalsettlementsandrelatedfees Legalsettlementsandrelatedfees	1890000000	USD
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	76000000	USD
CY2021Q4	bhc	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	340000000	USD
CY2021	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1375000000	USD
CY2020	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1645000000	USD
CY2019	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1897000000	USD
CY2021	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
CY2020	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2019	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	234000000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	114000000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75000000	USD
CY2021	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	50000000	USD
CY2020	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	22000000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-502000000	USD
CY2019	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	31000000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-373000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1426000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	450000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	676000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-203000000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000000	USD
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1426000000	USD
CY2020	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1534000000	USD
CY2019	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1612000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-59000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-42000000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7000000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-30000000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1024000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-934000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1837000000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	269000000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	302000000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	270000000	USD
CY2020	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
CY2021	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
CY2019	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8434000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8027000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8601000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8434000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8027000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8601000000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1598000000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1567000000	USD

Files In Submission

Name	View Source	Status
0000885590-22-000027-index-headers.html	Edgar Link	pending
0000885590-22-000027-index.html	Edgar Link	pending
0000885590-22-000027.txt	Edgar Link	pending
0000885590-22-000027-xbrl.zip	Edgar Link	pending
bhc-20220510.htm	Edgar Link	pending
bhc-20220510.xsd	Edgar Link	pending
bhc-20220510_cal.xml	Edgar Link	unprocessable
bhc-20220510_d2.htm	Edgar Link	pending
bhc-20220510_def.xml	Edgar Link	unprocessable
bhc-20220510_htm.xml	Edgar Link	completed
bhc-20220510_lab.xml	Edgar Link	unprocessable
bhc-20220510_pre.xml	Edgar Link	unprocessable
bhc5422-ex991.htm	Edgar Link	pending
bhc8-k542022ex23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2021 Q4 Form 8-K Financial Statement

#000088559022000027 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2021 Q4 Form 8-K Financial Statement

#000088559022000027 Filed on May 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc